Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
History
Social responsibility
Our companies
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A.
Debioclinic S.A.
Debiovision Inc.
Debioinnovation S.A.
Business Model
Strengths
Development capabilites
Preclinical
Clinical
Manufacturing
Regulatory
Innovative drug delivery and formulation
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Commercial Products
Eloxatin®
Decapeptyl®
News & Events
Press Releases
Awards
Publications
Conferences
News
02.09.2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21.08.2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology
Home
News & Events
Press Releases
PRESS RELEASES
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
27-Apr-2008
Clinical Update – Debio 025 in Hepatitis C - Presentation of Phase IIa Efficacy Results
18-Apr-2007
Clinical update - Debio 025 cyclophilin inhibitor for the treatment of HCV - A unique viral kinetics
30-Oct-2006
Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor for Debio-025
08-Feb-2006
Debiopharm S.A. presented results of a double-blind placebo-controlled study on first-in-class Debio-025 in HIV-1-infected subjects
05-Oct-2004
New Data presented on Debiopharm´s Debio-025 at the 11th International Symposium on Hepatits C virus and related viruses
< Prev
1
Next >
Results 1 - 5 of 5
Triptorelin – Trelstar® – Decapeptyl® - Pamorelin®
( 8 items )
Debio 8609 Sanvar®
( 12 items )
Debio 9902 - ZT-1
( 8 items )
Debio 0614 (istaroxime)
( 2 items )
Debio 0507
( 3 items )
Debio 0719
( 1 items )
Debio 0824
( 1 items )
Debio 0617
( 1 items )
Oxaliplatin – Eloxatin® – Elplat®
( 10 items )
Moapar® - Salvacyl®
( 3 items )
Other News
( 45 items )
